ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Arun Chandavarkar
News »
latest
by relevance
Biocon's revenues Rs 1090cr, EBITDA Rs 335cr, PAT Rs 225cr
Apr 23, 2008 at 19:02
Biocon Group Revenues Rs 1,090cr, EBITDA Rs 335cr, PAT Rs 225cr. Earnings per share at Rs 22.5 for the year.
Statin prices to be under pressure: Biocon
Apr 19, 2007 at 16:01
Biocon has come out with its fourth quarter results. The company posted consolidated net profit of Rs 60.7 crore (Rs 607 million) in fourth quarter versus Rs 48 crore (Rs 480 million) in corresponding quarter of previous year.
Biocon's FY 2006-07 performance shows healthy growth
Apr 19, 2007 at 10:40
Biocon's FY 2006-07 performance shows healthy growth. Revenues Rs 990 cr, EBITDA Rs 287cr, PAT Rs 200cr
Pricing pressure to continue: Biocon
Apr 19, 2007 at 10:39
Biocon has come out with its fourth quarter results. The company posted consolidated net profit of Rs 60.7 crore (Rs 607 million) in fourth quarter versus Rs 48 crore (Rs 480 million) in corresponding quarter of previous year.
Biocon's revenues Rs 1090cr, EBITDA Rs 335cr, PAT Rs 225cr
Apr 23, 2008 at 19:02
Biocon Group Revenues Rs 1,090cr, EBITDA Rs 335cr, PAT Rs 225cr. Earnings per share at Rs 22.5 for the year.
Statin prices to be under pressure: Biocon
Apr 19, 2007 at 16:01
Biocon has come out with its fourth quarter results. The company posted consolidated net profit of Rs 60.7 crore (Rs 607 million) in fourth quarter versus Rs 48 crore (Rs 480 million) in corresponding quarter of previous year.
Pricing pressure to continue: Biocon
Apr 19, 2007 at 10:39
Biocon has come out with its fourth quarter results. The company posted consolidated net profit of Rs 60.7 crore (Rs 607 million) in fourth quarter versus Rs 48 crore (Rs 480 million) in corresponding quarter of previous year.
Biocon's FY 2006-07 performance shows healthy growth
Apr 19, 2007 at 10:40
Biocon's FY 2006-07 performance shows healthy growth. Revenues Rs 990 cr, EBITDA Rs 287cr, PAT Rs 200cr
Videos »
Statin prices to be under pressure: Biocon
Pricing pressure to continue: Biocon
more »
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window
/ 
/
/